Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company ...
Q2 2026
Aug 11, 2026
Q1 2026
May 13, 2026
FY 2025
Mar 25, 2026
Q4 2025
Q3 2025
Nov 13, 2025